Predicted change in utility from the linear regression, comparing individuals with and without any hospitalisation, for any-cause and disease-specific hospitalisations, by gender
| Men | Women | |||
|---|---|---|---|---|
| Predicted additional change in utility | 95% CI | Predicted additional change in utility | 95% CI | |
| (A) Any-cause hospitalisation | ||||
| Crude model | −0.012 | (−0.028 to 0.005) | −0.025 | (−0.044 to −0.006) |
| Adjusted for age | −0.009 | (−0.025 to 0.008) | −0.020 | (−0.040 to −0.001) |
| Adjusted for age and education | −0.009 | (−0.026 to 0.008) | −0.022 | (−0.041 to −0.002) |
| Adjusted for age, education and utility at baseline (2006) | −0.016 | (−0.032 to −0.001) | −0.031 | (−0.049 to −0.014) |
| Adjusted for age, education, utility at baseline (2006) and maximum number of hospitalisation events (max=9) | 0.006 | (−0.018 to 0.029) | −0.038 | (−0.011 to 0.065) |
| Adjusted for age, education, utility at baseline (2006), maximum number of hospitalisation events (max=9) and time (in days) since last hospitalisation | −0.057 | (−0.111 to −0.002) | −0.027 | (−0.081 to 0.026) |
| (B) Disease-specific hospitalisations | ||||
| Predicted change in utility if any hospitalisation is due to a hip fracture* | −0.008 | (−0.016 to 0.000) | −0.014 | (−0.023 to −0.005) |
| Predicted change in utility if any hospitalisation is due to a myocardial infarction* | −0.009 | (−0.016 to −0.001) | −0.016 | (−0.025 to −0.008) |
| Predicted change in utility if any hospitalisation is due to stroke* | −0.008 | (−0.016 to 0.000) | −0.015 | (−0.024 to −0.007) |
| Predicted change in utility if any hospitalisation is due to CVD* | −0.010 | (−0.019 to −0.001) | −0.016 | (−0.026 to −0.007) |
| Predicted change in utility if any hospitalisation is due to cancer* | −0.008 | (−0.017 to 0.000) | −0.016 | (−0.025 to −0.007) |
*Adjusted for age, education and utility at baseline (2006).
CVD, cardiovascular disease.